​
​

Caribou Biosciences (CRBU) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Caribou Biosciences Revenue Highlights

Latest Revenue (Y)

$34.48M

Latest Revenue (Q)

$3.46M

Main Geography (Y)

UNITED STATES

Caribou Biosciences Revenue by Period

Caribou Biosciences Revenue by Year

DateRevenueChange
2023-12-31$34.48M148.91%
2022-12-31$13.85M44.31%
2021-12-31$9.60M-22.35%
2020-12-31$12.36M113.56%
2019-12-31$5.79M-

Caribou Biosciences generated $34.48M in revenue during NA 2023, up 148.91% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Caribou Biosciences Revenue by Quarter

DateRevenueChange
2024-06-30$3.46M42.61%
2024-03-31$2.43M-31.73%
2023-12-31$3.56M-84.96%
2023-09-30$23.66M530.15%
2023-06-30$3.75M7.22%
2023-03-31$3.50M-5.15%
2022-12-31$3.69M11.78%
2022-09-30$3.30M-21.21%
2022-06-30$4.19M57.36%
2022-03-31$2.66M4.10%
2021-12-31$2.56M-35.66%
2021-09-30$3.98M169.44%
2021-06-30$1.48M-6.94%
2021-03-31$1.59M61.18%
2020-12-31$984.00K-17.86%
2020-09-30$1.20M-85.87%
2020-06-30$8.48M398.41%
2020-03-31$1.70M-

Caribou Biosciences generated $3.46M in revenue during Q2 2024, up 42.61% compared to the previous quarter, and up 98.91% compared to the same period a year ago.

Caribou Biosciences Revenue Breakdown

Caribou Biosciences Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22Dec 21
Non-US$1.71M$548.00K$685.00K
UNITED STATES$32.77M$13.30M$8.91M

Caribou Biosciences's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (95.05%), and Non-US (4.95%).

Quarterly Revenue by Country

CountrySep 24Mar 24Dec 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21
UNITED STATES$1.66M$2.27M$2.35M$3.75M$3.38M$3.54M$2.97M$4.18M$2.61M$2.43M$3.51M$1.48M
Non-US$367.00K$160.00K$1.20M$9.00K$117.00K$150.00K$337.00K$9.00K$52.00K$129.00K--
Non Us----------$470.00K$111.00K

Caribou Biosciences's latest quarterly revenue breakdown by geography, as of Sep 24: UNITED STATES (81.87%), and Non-US (18.13%).

Caribou Biosciences Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
BEAMBeam Therapeutics$377.71M$14.27M
CRSPCRISPR Therapeutics$370.00M$602.00K
ADPTAdaptive Bio$170.28M$46.44M
FATEFate Therapeutics$63.53M$6.77M
NTLAIntellia Therapeutics$36.27M$9.11M
CRBUCaribou Biosciences$34.48M$3.46M
VERVVerve Therapeutics$11.76M$6.87M
EDITEditas Medicine--
PRMEPrime Medicine-$39.31M
SANASana Bio--

CRBU Revenue FAQ

What is Caribou Biosciences’s yearly revenue?

Caribou Biosciences's yearly revenue for 2023 was $34.48M, representing an increase of 148.91% compared to 2022. The company's yearly revenue for 2022 was $13.85M, representing an increase of 44.31% compared to 2021. CRBU's yearly revenue for 2021 was $9.6M, representing a decrease of -22.35% compared to 2020.

What is Caribou Biosciences’s quarterly revenue?

Caribou Biosciences's quarterly revenue for Q2 2024 was $3.46M, a 42.61% increase from the previous quarter (Q1 2024), and a -7.75% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $2.43M, a -31.73% decrease from the previous quarter (Q4 2023), and a -30.64% decrease year-over-year (Q1 2023). CRBU's quarterly revenue for Q4 2023 was $3.56M, a -84.96% decrease from the previous quarter (Q3 2023), and a -3.63% decrease year-over-year (Q4 2022).

What is Caribou Biosciences’s revenue growth rate?

Caribou Biosciences's revenue growth rate for the last 3 years (2021-2023) was 259.21%, and for the last 5 years (2019-2023) was 495.66%.